Community Research and Development Information Service - CORDIS


An increase of osteosarcoma cases was observed in all experimental groups down to a skeletal alpha-dose of 0.15 Gy. The protracted application showed in the higher dose ranges a multiple effect compared to that of single administration and was even in the lowest dose ranges never less than that of single administration.

Additional information

Authors: MÜLLER W A, Gesellschaft für Strahlen- und Umweltforschung mbH München, Neuherberg (DE);MULLER W A, Gesellschaft fur Strahlen- und Umweltforschung mbH Munchen, Neuherberg (DE)
Bibliographic Reference: Paper presented: Seminar of the Battelle Pacific Northwest Laboratories, Richland/Washington (US), Oct. 17, 1988
Availability: Text not available
Record Number: 198910865 / Last updated on: 1994-12-01
Original language: en
Available languages: en